|
US4440859A
(en)
|
1977-05-27 |
1984-04-03 |
The Regents Of The University Of California |
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
YU44186B
(en)
|
1978-12-22 |
1990-04-30 |
Biogen Nv |
Process for obtaining recombinant dnk molecules
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
|
US4766075A
(en)
|
1982-07-14 |
1988-08-23 |
Genentech, Inc. |
Human tissue plasminogen activator
|
|
US4582800A
(en)
|
1982-07-12 |
1986-04-15 |
Hoffmann-La Roche Inc. |
Novel vectors and method for controlling interferon expression
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4677063A
(en)
|
1985-05-02 |
1987-06-30 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4810648A
(en)
|
1986-01-08 |
1989-03-07 |
Rhone Poulenc Agrochimie |
Haloarylnitrile degrading gene, its use, and cells containing the gene
|
|
US4897445A
(en)
|
1986-06-27 |
1990-01-30 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide bond
|
|
CA2163032C
(en)
|
1993-06-03 |
2001-02-06 |
John Landon |
Antibody fragments in therapy
|
|
AUPM322393A0
(en)
|
1993-12-24 |
1994-01-27 |
Austin Research Institute, The |
Mucin carbohydrate compounds and their use in immunotherapy
|
|
US6805861B2
(en)
|
1996-01-17 |
2004-10-19 |
Imperial College Innovations Limited |
Immunotherapy using cytotoxic T lymphocytes (CTL)
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
WO1999046276A1
(en)
*
|
1998-03-13 |
1999-09-16 |
Genos Biosciences, Inc. |
Zap-1 tumor associated genes and their uses
|
|
EP1568373A3
(en)
*
|
1999-12-10 |
2005-12-21 |
Epimmune Inc. |
Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
EP1294748B1
(en)
|
2000-03-27 |
2010-06-30 |
Technion Research and Development of Foundation, Ltd. |
Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
|
|
EP2322228B1
(en)
|
2000-06-05 |
2018-01-10 |
Altor BioScience Corporation |
T cell receptor fusion proteins and conjugates and methods of use thereof
|
|
WO2002066501A2
(en)
*
|
2001-01-02 |
2002-08-29 |
Hybrigenics |
PROTEIN-PROTEIN INTERACTIONS IN $i(HELICOBACTER PYLORI)
|
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
EP1451305A4
(en)
*
|
2001-11-07 |
2005-10-05 |
Mannkind Corp |
EPITOPE SYNCHRONIZATION IN CELLS THAT HAVE ANTIGENS
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
EP2048159B1
(en)
|
2002-11-09 |
2014-01-01 |
Immunocore Ltd. |
T cell receptor display
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
AU2004235382A1
(en)
*
|
2003-04-29 |
2004-11-11 |
Wyeth |
Methods for diagnosing AML and MDS differential gene expression
|
|
DE602005020046D1
(de)
|
2005-09-05 |
2010-04-29 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden
|
|
US20070248628A1
(en)
|
2005-12-06 |
2007-10-25 |
Keller Lorraine H |
Immunogens in cancer stem cells
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
WO2009036246A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Immunotope, Inc. |
Immunogens that induce cytotoxic t-lymphocytes and their use in prevention, treatment, and diagnosis of cancer
|
|
GB0721686D0
(en)
*
|
2007-11-05 |
2007-12-12 |
Medinnova As |
Polypeptides
|
|
US20090263574A1
(en)
|
2008-04-21 |
2009-10-22 |
Quinn Daniel E |
Method of restoring an article
|
|
ES2536465T3
(es)
*
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
EP2458014A1
(en)
|
2010-09-07 |
2012-05-30 |
Rijksuniversiteit Groningen |
Prognostic markers for acute myeloid leukemia (AML)
|
|
EP2632955A1
(en)
|
2010-10-26 |
2013-09-04 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
|
WO2013009818A2
(en)
*
|
2011-07-11 |
2013-01-17 |
Gevo, Inc. |
High-performance ketol-acid reductoisomerases
|
|
EP2771349B1
(en)
*
|
2011-09-16 |
2020-02-26 |
Iogenetics, LLC. |
Bioinformatic processes for determination of peptide binding
|
|
WO2013057586A1
(en)
|
2011-10-19 |
2013-04-25 |
Oslo Universitetssykehus Hf |
Compositions and methods for producing soluble t - cell receptors
|
|
WO2013071154A1
(en)
*
|
2011-11-11 |
2013-05-16 |
Fred Hutchinson Cancer Research Center |
Cyclin a1-targeted t-cell immunotherapy for cancer
|
|
US10501512B2
(en)
*
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
MX364370B
(es)
*
|
2012-07-12 |
2019-04-24 |
Persimmune Inc |
Vacunas contra el cancer personalizadas y terapias de celulas inmunes adoptivas.
|
|
WO2014071978A1
(en)
|
2012-11-08 |
2014-05-15 |
Roche Diagnostics Gmbh |
Nucleic acids encoding chimeric polypeptides for library screening
|
|
LT2945647T
(lt)
*
|
2013-01-15 |
2021-02-25 |
Memorial Sloan Kettering Cancer Center |
Imunogeniniai wt-1 peptidai ir jų panaudojimo būdai
|
|
EP2808392A1
(en)
|
2013-05-28 |
2014-12-03 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
TWI714869B
(zh)
*
|
2013-08-05 |
2021-01-01 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
|
|
WO2015150491A1
(en)
*
|
2014-04-01 |
2015-10-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An isolated donor mhc-derived peptide and uses thereof
|
|
US10137181B2
(en)
*
|
2014-04-01 |
2018-11-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Isolated donor MHC-derived peptide and uses thereof
|
|
GB201408255D0
(en)
*
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
MA43482A1
(fr)
*
|
2016-04-06 |
2019-05-31 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides pour une utilisation dans l'immunothérapie contre la leucémie myéloïde aiguë (lma) et d'autres cancers
|